FAT10ylation as a signal for proteasomal degradation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 1, 2014, Pages 97-102

  Schmidtke, Gunter ^a   Aichem, Annette ^a,b   Groettrup, Marcus ^a,b  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF KONSTANZ   (Switzerland)

Author keywords

Degradation; FAT10; NUB1L; Proteasome; Ubiquitin

Indexed keywords

FAT10 PROTEIN; LYSINE; PROTEASOME; PROTEIN MAD2; PROTEIN PRECURSOR; SMALL INTERFERING RNA; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

AGGRESOME; AUTOPHAGOSOME; CELL STRAIN HEK293; DEGRADATION; IN VITRO STUDY; M PHASE CELL CYCLE CHECKPOINT; PRECIPITATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; UBIQUITINATION;

EID: 84890183307     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.01.009     Document Type: Review

References (50)

1. Ciechanover A., Hod Y., Hershko A. A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem. Biophys. Res. Commun. 1978, 81:1100-1105.
2. Hershko A., Ciechanover A., Varshavsky A. The ubiquitin system. Nat. Med. 2000, 6:1073-1081.
3. Ciechanover A., Heller H., Katz-Etzion R., Hershko A. Activation of the heat-stable polypeptide of the ATP-dependent proteolytic system. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:761-765.
4. Pelzer C., Kassner I., Matentzoglu K., Singh R.K., Wollscheid H.P., Scheffner M., Schmidtke G., Groettrup M. UBE1L2, a novel E1 enzyme specific for ubiquitin. J. Biol. Chem. 2007, 282:23010-23014.
5. Jin J.P., Li X., Gygi S.P., Harper J.W. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature 2007, 447:1135-1137.
6. Chiu Y.H., Sun Q., Chen Z.J. E1-L2 activates both ubiquitin and FAT10. Mol. Cell 2007, 27:1014-1023.
7. Groettrup M., Pelzer C., Schmidtke G., Hofmann K. Activating the ubiquitin family: UBA6 challenges the field. Trends Biochem. Sci. 2008, 33:230-237.
8. Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 2009, 78:477-513.
9. Kerscher O., Felberbaum R., Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 2006, 22:159-180.
10. Carlson N., Rechsteiner M. Microinjection of ubiquitin: intracellular distribution and metabolism in HeLa cells maintained under normal physiological conditions. J. Cell Biol. 1987, 104:537-546.
11. Hiroi Y., Rechsteiner M. Ubiquitin metabolism in HeLa cells starved of amino acids. FEBS Lett. 1992, 307:156-161.
12. Wilkinson K.D. DUBs at a glance. J. Cell Sci. 2009, 122:2325-2329.
13. Thrower J.S., Hoffman L., Rechsteiner M., Pickart C.M. Recognition of the polyubiquitin proteolytic signal. EMBO J. 2000, 19:94-102.
14. Xu P., Duong D.M., Seyfried N.T., Cheng D.M., Xie Y., Robert J., Rush J., Hochstrasser M., Finley D., Peng J. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009, 137:133-145.
15. Deveraux Q., Ustrell V., Pickart C., Rechsteiner M. A 26S protease subunit that binds ubiquitin conjugates. J. Biol. Chem. 1994, 269:7059-7061.
16. Husnjak K., Elsasser S., Zhang N.X., Chen X., Randles L., Shi Y., Hofmann K., Walters K.J., Finley D., Dikic I. Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature 2008, 453:481-488.
17. Tatham M.H., Geoffroy M.C., Shen L., Plechanovova A., Hattersley N., Jaffray E.G., Palvimo J.J., Hay R.T. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 2008, 10:538-546.
18. LallemandBreitenbach V., Jeanne M., Benhenda S., Nasr R., Lei M., Peres L., Zhou J., Zhu J., Raught B., deThe H. Arsenic degrades PML or PML-RAR alpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 2008, 10:547-555.
19. Weisshaar S.R., Keusekotten K., Krause A., Horst C., Springer H.M., Gottsche K., Dohmen R.J., Praefcke G.J. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML. FEBS Lett. 2008, 582:3174-3178.
20. Hipp M.S., Kalveram B., Raasi S., Groettrup M., Schmidtke G. FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol. Cell. Biol. 2005, 25:3483-3491.
21. Schmidtke G., Kalveram B., Groettrup M. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L. FEBS Lett. 2009, 583:591-594.
22. Rani N., Aichem A., Schmidtke G., Kreft S.G., Groettrup M. FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysis. Nat. Commun. 2012, 3:749. 10.1038/ncomms1752.
23. Buchsbaum S., Bercovich B., Ciechanover A. FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination. Mol. Biol. Cell 2012, 23:225-232.
24. Fan W., Cai W., Parimoo S., Lennon G.G., Weissman S.M. Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics 1996, 44:97-103.
25. Narasimhan J., Wang M., Fu Z.J., Klein J.M., Haas A.L., Kim J.J.P. Crystal structure of the interferon-induced ubiquitin-like protein ISG15. J. Biol. Chem. 2005, 280:27356-27365.
26. Lee C.G., Ren J., Cheong I.S., Ban K.H., Ooi L.L., Yong Tan S., Kan A., Nuchprayoon I., Jin R., Lee K.H., Choti M., Lee L.A. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 2003, 22:2592-2603.
27. Lukasiak S., Schiller C., Oehlschlaeger P., Schmidtke G., Krause P., Legler D.F., Autschbach F., Schirmacher P., Breuhahn K., Groettrup M. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 2008, 27:6068-6074.
28. Canaan A., Yu X.F., Booth C.J., Lian J., Lazar I., Gamfi S.L., Castille K., Kohya N., Nakayama Y., Liu Y.C., Eynon E., Flavell R., Weissman S.M. FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol. Cell. Biol. 2006, 26:5180-5189.
29. Raasi S., Schmidtke G., Giuli R.d., Groettrup M. A ubiquitin-like protein which is synergistically inducible by interferon-γ and tumor necrosis factor-α. Eur. J. Immunol. 1999, 29:4030-4036.
30. Liu Y., Pan J., Zhang C., Fan W., Collinge M., Bender J.R., Weissman S.M. A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:4313-4318.
31. Aichem A., Kalveram B., Spinnenhirn V., Kluge K., Catone N., Johansen T., Groettrup M. The proteomic analysis of FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation. J. Cell Sci. 2012, 125:4576-4585.
32. Ebstein F., Lange N., Urban S., Seifert U., Kruger E., Kloetzel P.M. Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int. J. Biochem. Cell Biol. 2009, 41:1205-1215.
33. Gavin J.M., Chen J.J., Liao H., Rollins N., Yang X.F., Xu Q., Ma J.Y., Loke H.K., Lingaraj T., Brownell J.E., Mallender W.D., Gould A.E., Amidon B.S., Dick L.R. Mechanistic studies on activation of ubiquitin and di-ubiquitin-like protein, FAT10, by ubiquitin-like modifier activating enzyme 6, Uba6. J. Biol. Chem. 2012, 287:15512-15522.
34. Aichem A., Pelzer C., Lukasiak S., Kalveram B., Sheppard P.W., Rani N., Schmidtke G., Groettrup M. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis. Nat. Commun. 2010, 1:13.
35. Gu X., Zhao F., Zheng M., Fei X., Chen X., Huang S., Xie Y., Mao Y. Cloning and characterization of a gene encoding the human putative ubiquitin conjugating enzyme E2Z (UBE2Z). Mol. Biol. Rep. 2007, 34:183-188.
36. Raasi S., Schmidtke G., Groettrup M. The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J. Biol. Chem. 2001, 276:35334-35343.
37. Schliehe C., Bitzer A., van den Broek M., Groettrup M. Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo. J. Virol. 2012, 86:9782-9793.
38. Ebstein F., Lehmann A., Kloetzel P.M. The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation. Cell. Mol. Life Sci. 2012, 69:2443-2454.
39. Kamitani T., Kito K., Fukuda-Kamitani T., Yeh E.T.H. Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J. Biol. Chem. 2001, 276:46655-46660.
40. Kito K., Yeh E.T.H., Kamitani T. NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J. Biol. Chem. 2001, 276:20603-20609.
41. Hipp M.S., Raasi S., Groettrup M., Schmidtke G. NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. J. Biol. Chem. 2004, 279:16503-16510.
42. Schmidtke G., Kalveram B., Weber E., Bochtler P., Lukasiak S., Hipp M.S., Groettrup M. The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10. J. Biol. Chem. 2006, 281:20045-20054.
43. Verma R., Oania R., Graumann J., Deshaies R.J. Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell 2004, 118:99-110.
44. Tanji K., Tanaka T., Kamitani T. Interaction of NUB1 with the proteasome subunit S5a. Biochem. Biophys. Res. Commun. 2005, 337:116-120.
45. Ross M.J., Wosnitzer M.S., Ross M.D., Granelli B., Gusella G.L., Husain M., Kaufman L., Vasievich M., D'Agati V.D., Wilson P.D., Klotman M.E., Klotman P.E. Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease. J. Am. Soc. Nephrol. 2006, 17:996-1004.
46. Buchsbaum S., Bercovich B., Ziv T., Ciechanover A. Modification of the inflammatory mediator LRRFIP2 by the ubiquitin-like protein FAT10 inhibits its activity during cellular responses to LPS. Biochem. Biophys. Res. Com. 2012, 428:11-16.
47. Ren J.W., Kan A., Leong S.H., Ooi L.L.P.J., Jeang K.T., Chong S.S., Kon O.L., Lee C.G.L. FAT10 plays a role in the regulation of chromosomal stability. J. Biol. Chem. 2006, 281:11413-11421.
48. Ren J.W., Wang Y., Gao Y., Mehta S.B.K., Lee C.G.L. FAT10 mediates the effect of TNF-alpha in inducing chromosomal instability. J. Cell Sci. 2011, 124:3665-3675.
49. Oliva J., BardagGorce F., French B.A., Li J., McPhaul L., Amidi F., Dedes J., Habibi A., Nguyen S., French S.W. Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis. Exp. Mol. Pathol. 2008, 84:102-112.
50. Kalveram B., Schmidtke G., Groettrup M. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition. J. Cell Sci. 2008, 121:4079-4088.